HeartBeam, Inc. is a cardiac technology company. The Company is focusing on developing and commercializing higher resolution ambulatory Electrocardiogram (ECG) solutions that enable the detection and monitoring of cardiac disease both inside and outside a healthcare facility setting. The Company is engaged in the development of its proprietary and patented Vector Electrocardiography (VECG) technology platform. Its VECG is capable of developing three-dimensional vector images of cardiac electrical activity by displaying the spatial locations of ECG waveforms. It has two patented products in development, such as HeartBeam AIMI and HeartBeam AIMIGo. HeartBeam AIMI is software for acute care settings that provides a 3D comparison of baseline and symptomatic 12-lead ECG to identify a heart attack. HeartBeam AIMIGo is a credit card-sized 12-lead output ECG device coupled with a smart phone app and cloud-based diagnostic software system to facilitate remote evaluation of cardiac symptoms.

Employees

Sector

Advanced Medical Equipment & Technology

Calendar

11/12/2024 - Q3 2024 Earnings Release (Projected)

More about the company

Quotes

Date	Price	Change	Volume
12/09/24	2.240 $	-0.44%	47,300
11/09/24	2.250 $	-0.88%	20,132
10/09/24	2.270 $	-3.40%	62,091
09/09/24	2.350 $	+1.73%	28,440
06/09/24	2.310 $	-6.48%	64,765

Delayed Quote Nasdaq, September 12, 2024 at 09:00 pm

More quotes

Income Statement and Estimates

More financial data

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

2.240USD

Average target price

5.000USD

Spread / Average Target

+123.21%

Consensus

Profit revisions

Estimate revisions

Quarterly earnings, Rate of surprise

Company calendar

Market Closed - Nasdaq Other stock markets 21:00:00 12/09/2024 BST			5-day change	1st Jan Change
2.240 ^USD	-0.44%		-9.31%	-4.68%

09-10	HeartBeam, Inc. Appoints Timothy Cruickshank as Chief Financial Officer	CI
08-14	Transcript : HeartBeam, Inc., Q2 2024 Earnings Call, Aug 14, 2024

Capitalization	59.5M 4.53B	P/E ratio 2024 *	-3.2x	P/E ratio 2025 *	-4.19x
Enterprise value	61.87M 4.71B	EV / Sales 2024 *	-	EV / Sales 2025 *	9.6x
Free-Float	70.75%	Yield 2024 *	-	Yield 2025 *	-

HeartBeam, Inc. Appoints Timothy Cruickshank as Chief Financial Officer	09-10	CI
Transcript : HeartBeam, Inc., Q2 2024 Earnings Call, Aug 14, 2024	08-14
HeartBeam, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2024	08-14	CI
HeartBeam, Inc.(NasdaqCM:BEAT) added to Russell Microcap Growth Index	06-30	CI
HeartBeam, Inc.(NasdaqCM:BEAT) added to Russell 3000E Index	06-30	CI
HeartBeam, Inc.(NasdaqCM:BEAT) added to Russell Microcap Index	06-30	CI
HeartBeam, Inc.(NasdaqCM:BEAT) added to Russell 3000E Growth Index	06-30	CI
HeartBeam, Inc. Announces New Study Data Demonstrating That HeartBeam AI Combined with Vectorcardiography Outperforms Expert Cardiologists in Detecting Arrhythmias	05-20	CI
Transcript : HeartBeam, Inc., Q1 2024 Earnings Call, May 09, 2024	05-09
HeartBeam, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-09	CI
HeartBeam, Inc. Presents Positive Results on its Artificial Intelligence Capabilities for Detecting Arrhythmias	04-09	CI
Transcript : HeartBeam, Inc., Q4 2023 Earnings Call, Mar 20, 2024	03-20
HeartBeam, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	03-20	CI

Alliance Global Partners Initiates HeartBeam at Buy With $10 Price Target	02/12/22	MT
Dawson James Initiates Coverage on HeartBeam With Buy Rating, $12 Price Target	25/07/22	MT
Benchmark Initiates HeartBeam at Speculative Buy With $9 Price Target	20/12/21	MT

HeartBeam, Inc. Share Price

Equities

BEAT

US42238H1086

Advanced Medical Equipment & Technology

Valuation: HeartBeam, Inc.

Chart: HeartBeam, Inc.

Latest news: HeartBeam, Inc.

Last Transcript: HeartBeam, Inc.

Analysts' recommendations: HeartBeam, Inc.

Press Releases: HeartBeam, Inc.

Quotes and Performance

Course Extremes

Managers and Directors: HeartBeam, Inc.

Medical Diagnostic & Testing Equipment

Financials

Company Profile

Quotes

Income Statement and Estimates

Analysts' Consensus

Quarterly earnings, Rate of surprise

HeartBeam Names Timothy Cruickshank as Chief Financial Officer	09-10	BU
HeartBeam : Earnings Documents	09-09	PU
HeartBeam : Earnings Documents	08-21	PU
HeartBeam : Second Quarter 2024 Earnings Conference Call Presentation	08-14	PU
HeartBeam : Earnings Documents	08-14	PU

1 day	-0.44%
1 week	-9.31%
Current month	-4.68%
1 month	+0.45%
3 months	-0.88%
6 months	-3.45%
Current year	-4.68%

Director	Title	Age	Since
Branislav Vajdic FOU	Founder	70	31/12/14
Timothy Cruickshank DFI	Director of Finance/CFO	43	08-08
Robert Eno PSD	President	-	17/01/23

Add to a list Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5d. change	1-year change	3-years change	Capi. ($)
HEARTBEAM, INC.	-0.44%	-9.31%	+14.29%	-	59.5M
SARTORIUS AG	-0.78%	+2.23%	-27.09%	-57.03%	16.67B
QUIDELORTHO CORPORATION	-0.11%	+0.67%	-39.23%	-70.02%	3.01B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	-3.65%	-7.75%	+29.60%	+188.39%	1.38B
BIOTAGE AB	+0.68%	-2.18%	+70.25%	-27.62%	1.42B
SHANGHAI MICROPORT EP MEDTECH CO., LTD.	+1.32%	-3.80%	-5.27%	-	1.27B
REVENIO GROUP OYJ	+0.64%	+3.57%	+62.35%	-42.51%	1.01B
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	-0.62%	-0.29%	-29.44%	-	783M
CONTEC MEDICAL SYSTEMS CO.,LTD	+1.24%	-0.76%	-39.50%	-65.86%	735M
CELLAVISION AB	+0.55%	+2.22%	+67.07%	-38.03%	631M
Average	-0.11%	-0.31%	+10.30%	-16.10%	2.7B
Weighted average by Cap.	-0.53%	+2.32%	-14.15%	-42.46%

	2024 *	2025 *
Net sales	-	6.2M 472M
Net income	-18.66M -1.42B	-9.8M -746M
Net Debt	-	-

Manager	Title	Age	Since
Branislav Vajdic FOU	Founder	70	31/12/14
Willem Elfrink BRD	Director/Board Member	72	10/06/15
Richard Ferrari CHM	Chairman	70	31/12/18